1. Home
  2. WST vs BNT Comparison

WST vs BNT Comparison

Compare WST & BNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • BNT
  • Stock Information
  • Founded
  • WST 1923
  • BNT 2020
  • Country
  • WST United States
  • BNT Bermuda
  • Employees
  • WST N/A
  • BNT N/A
  • Industry
  • WST Medical/Dental Instruments
  • BNT
  • Sector
  • WST Health Care
  • BNT
  • Exchange
  • WST Nasdaq
  • BNT Nasdaq
  • Market Cap
  • WST 15.6B
  • BNT 14.4B
  • IPO Year
  • WST N/A
  • BNT N/A
  • Fundamental
  • Price
  • WST $215.84
  • BNT $59.00
  • Analyst Decision
  • WST Strong Buy
  • BNT
  • Analyst Count
  • WST 6
  • BNT 0
  • Target Price
  • WST $349.00
  • BNT N/A
  • AVG Volume (30 Days)
  • WST 587.7K
  • BNT 10.2K
  • Earning Date
  • WST 07-24-2025
  • BNT 08-07-2025
  • Dividend Yield
  • WST 0.39%
  • BNT 0.58%
  • EPS Growth
  • WST N/A
  • BNT N/A
  • EPS
  • WST 6.37
  • BNT 2.28
  • Revenue
  • WST $2,895,800,000.00
  • BNT $14,236,000,000.00
  • Revenue This Year
  • WST $3.38
  • BNT N/A
  • Revenue Next Year
  • WST $5.85
  • BNT N/A
  • P/E Ratio
  • WST $34.09
  • BNT $26.09
  • Revenue Growth
  • WST N/A
  • BNT 73.14
  • 52 Week Low
  • WST $187.43
  • BNT $40.12
  • 52 Week High
  • WST $352.33
  • BNT $62.72
  • Technical
  • Relative Strength Index (RSI)
  • WST 48.07
  • BNT N/A
  • Support Level
  • WST $221.02
  • BNT N/A
  • Resistance Level
  • WST $230.27
  • BNT N/A
  • Average True Range (ATR)
  • WST 5.73
  • BNT 0.00
  • MACD
  • WST -0.20
  • BNT 0.00
  • Stochastic Oscillator
  • WST 40.05
  • BNT 0.00

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About BNT Brookfield Wealth Solutions Ltd.

Brookfield Wealth Solutions Ltd, formerly Brookfield Reinsurance Ltd operates a capital solutions business providing insurance and reinsurance services to individuals and institutions. Through its subsidiary, the company offers a broad range of insurance products and services, including life insurance and annuities, and personal and commercial property and casualty insurance. It is organized into three reporting segments: Direct Insurance, Reinsurance, and Pension Risk Transfer (PRT).

Share on Social Networks: